[PDF][PDF] 近距离放疗治疗≤ cT3 期前列腺癌的远期疗效及影响预后的危险因素
王增增， 李月明， 徐勇 - 临床泌尿外科杂志, 2024 - lcmw.whuhzzs.com
近距离放疗治疗≤cT3期前列腺癌的远期疗效及影响预后的危险因素 Page 1 2024年 临床泌尿
外科杂志 39卷4期 JClinUrol(China) 引用本文:王增增,李月明,徐勇.近距离放疗治疗≤cT3期 …
外科杂志 39卷4期 JClinUrol(China) 引用本文:王增增,李月明,徐勇.近距离放疗治疗≤cT3期 …
Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer
Y Kusuhara, T Fukawa, T Fukumori, Y Ueno… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Intermediate-risk prostate cancer (PCa) is a highly heterogeneous
disease. Although low-dose-rate brachytherapy (LDR-BT) is mainly used for low-to …
disease. Although low-dose-rate brachytherapy (LDR-BT) is mainly used for low-to …
Clinical outcomes and predictors of ≤cT3 prostate cancer treated by 125I low-dose-rate prostate brachytherapy
W Zengzeng, LI Yueming, XU Yong - J Clin Urol, 2024 - lcmwen.whuhzzs.com
Clinical outcomes and predictors of ≤cT3 prostate cancer treated by <sup>125</sup>I low-dose-rate
prostate brachytherapy Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} …
prostate brachytherapy Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} …